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ABSTRACT
Objective: To determine whether neighbourhood
walkability is associated with clinical measures of
obesity, hypertension, diabetes and dyslipidaemia in an
urban adult population.
Design: Observational cross-sectional study.
Setting: Urban primary care patients.
Participants: 78 023 Toronto residents, aged
18 years and over, who were formally rostered or had
at least 2 visits between 2012 and 2014 with a primary
care physician participating in the University of Toronto
Practice Based Research Network (UTOPIAN), within
the Canadian Primary Care Sentinel Surveillance
Network (CPCSSN).
Main outcome measures: Differences in average
body mass index (BMI), systolic and diastolic blood
pressure, fasting blood glucose, haemoglobin A1c
(HbA1C), total cholesterol, high-density lipoprotein
(HDL), low-density lipoprotein and triglyceride between
residents in the highest versus the lowest quartile of
neighbourhood walkability, as estimated using
multivariable linear regression models and stratified by
age. Outcomes were objectively measured and were
retrieved from primary care electronic medical records.
Models adjusted for age, sex, smoking, medications,
medical comorbidities and indices of neighbourhood
safety and marginalisation.
Results: Compared with those in the lowest
walkability quartile, individuals in the highest quartile
had lower mean BMI (−2.64 kg/m2, 95% CI −2.98 to
−2.30; p<0.001), systolic blood pressure
(−1.35 mm Hg, 95% CI −2.01 to −0.70; p<0.001),
diastolic blood pressure (−0.60 mm Hg, 95% CI 1.06
to −0.14; p=0.010) and HbA1c (−0.063%, 95% CI
−0.11 to −0.021; p=0.003) and higher mean HDL
(0.052 mmol/L, 95% CI 0.029 to 0.075; p<0.001). In
age-stratified analyses, differences in the mean BMI
were consistently observed for adults aged 18 to under
40 (−4.44 kg/m2, 95% CI −5.09 to −3.79; p<0.001),
adults aged 40–65 (−2.74 kg/m2, 95% CI −3.24 to
−2.23; p<0.001) and adults aged over 65 (−0.87 kg/
m2, 95% CI −1.48 to −0.26; p=0.005).
Conclusions: There was a clinically meaningful
association between living in the most walkable
neighbourhoods and having lower BMI in adults
of all ages.
INTRODUCTION
Increasing physical activity can signiﬁcantly
impact disability-adjusted life years in devel-
oped countries. This is because many of the
top risk factors associated with excess mor-
bidity and mortality—high body mass index
(BMI), high blood pressure, high glycaemic
levels and high cholesterol—are all impacted
by exercise.1 Clinical practice guidelines con-
sistently recommend physical activity, as part
of a healthy lifestyle2–4 and as non-
pharmacological therapy for overweight and
obesity,5–8 hypertension,9–11 diabetes12–14 and
dyslipidaemia.15–17
At the population level, public health pro-
fessionals have advocated for the use of built
environment designs that support or
promote active transportation such as utilitar-
ian walking or cycling.18 19 Utilitarian
walking describes non-recreational walking
Strengths and limitations of this study
▪ This neighbourhood walkability study is unique
in examining a set of objectively measured meta-
bolic risk factors, all of which are known to
change with physical activity.
▪ We used electronic medical record data, which
allowed us to control for patient-level covariates
and express results in a clinically meaningful
way.
▪ It was not possible to control for diet or the food
environment with our study data.
▪ The cross-sectional study design could not rule
out a residential selection effect in which indivi-
duals with healthier lifestyles may choose to
reside in more walkable neighbourhoods.
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that is used as a mode of transportation, commonly in
the course of conducting errands, or travelling to and
from school or work.20 21 By recognising neighbourhood
design as a way to inﬂuence health behaviours and
‘build in’ physical activity into daily living, this popula-
tion health approach advances health promotion to
sectors beyond healthcare, towards the creation of
public policies and environments that support health.22
Multiple scales have been developed and validated to
measure aspects of a neighbourhood’s built environment
that promote pedestrian walking.23 24 Characteristics
such as residential density, intersection density and
public transport density have been shown to inﬂuence
walkability and physical activity.25 Current evidence sug-
gests that greater neighbourhood walkability is associated
with increased physical activity, through walking for trans-
port or utilitarian walking.26–31 Studies using survey or
administrative data have found associations between
areas of higher walkability and population-level health
outcomes such as lower prevalence and incidence of
obesity and diabetes,30 32–34 and lower incidence of
hypertension.35 However, there is limited information on
objectively measured metabolic risk factors which are
known to change with physical activity.
This study examined the association between relative
residential neighbourhood walkability and objectively
measured metabolic risk factors in an urban adult
population.
METHODS
This study used an observational cross-sectional design
and linked routinely collected electronic medical record
(EMR) data with neighbourhood-level characteristics.
Study population
The study population included patients, aged 18 and
above, seen by a primary care physician participating in
the University of Toronto Practice Based Research
Network (UTOPIAN). UTOPIAN is 1 of 11 Primary Care
Practice Based Research Networks that are part of the
Canadian Primary Care Sentinel Surveillance Network
(CPCSSN). CPCSSN is a multidisease surveillance system
where primary care physicians contribute deidentiﬁed
EMR data to a national database.36 In Canada, universal
access to primary care services is publicly funded, and in
the province of Ontario, where Toronto is situated, 94%
of residents have a primary care provider.37 Patients who
were enrolled with, or who had at least two visits with a
CPCSSN-UTOPIAN primary care physician between 1
January 2012 and 31 December 2014 and who had a
valid City of Toronto residential postal code were
included in this study. Data were extracted as of 31
December 2014 using procedures previously described.36
Measure of neighbourhood walkability
The walkability of each individual’s residential neigh-
bourhood was measured using Walk Score, a validated
index that calculates the walkability of an address based
on distance to amenities and aspects of pedestrian
friendliness, including population density, block length
and intersection density.38 Increasing Walk Score has
been linked to increased utilitarian walking and
decreased obesity prevalence in Ontario, Canada.29 In
this walkability index, locations are scored from 0 to 100,
where 100 is the most walkable.38 Toronto has 140
neighbourhoods, each of which is an administrative area
that covers several city blocks, and has a minimum popu-
lation of 7000–10 000.39 Neighbourhood-level Walk
Scores for all Toronto neighbourhoods are publicly avail-
able online40 and represent a population-weighted
aggregation of a grid of Walk Score points for the entire
area of a neighbourhood, as delineated by administrative
boundaries.38 The Walk Scores current as of 2014 were
retrieved.40 Based on their residential postal code, parti-
cipants were assigned to a Toronto neighbourhood
using Toronto neighbourhood and postal code area sha-
peﬁles41–43 with ESRI ArcGIS ArcMap V.10.1.
Health outcome measures
The health outcome measures in this study were BMI,
systolic and diastolic blood pressure (sBP, dBP), fasting
blood glucose (FBG), haemoglobin A1c (HbA1c), total
cholesterol (TC), high-density lipoprotein (HDL), low-
density lipoprotein (LDL) and triglyceride (TG). These
measures were selected because they represent widely
accepted indicators of obesity, hypertension, glycaemic
control and dyslipidaemia, for which target ranges are
well established in clinical practice guidelines.5–17 If mul-
tiple values were present between 2012 and 2014, the
most recent record was used for data analysis. Given that
the study sample was derived from a primary care
patient population, the collection of these health mea-
sures represented the full spectrum of clinical testing:
screening of healthy and at-risk individuals, diagnosis of
individuals and monitoring of individuals with chronic
conditions for disease control and therapy optimisation.
Covariates
Individual and neighbourhood-level covariates were
measured. Individual health and sociodemographic
characteristics obtained from CPCSSN-UTOPIAN data
included key variables that can inﬂuence the clinical
outcome measures of interest: patient age, sex, current
smoking status, presence of a diagnosis of hypertension
or diabetes and presence of a prescription for a
weight-loss medication, an antihypertensive medication,
an antidiabetic medication or a lipid-lowering medica-
tion. Diagnoses of hypertension and diabetes were based
on validated CPCSSN case deﬁnitions and case-ﬁnding
algorithms.44
Neighbourhood rates of violent crime reported to the
Toronto Police Service (ie, assault, sexual assault,
robbery and murder) were used as an indicator of
neighbourhood safety,45 given the possibility that neigh-
bourhood crime and perception of safety may inﬂuence
2 Loo CKJ, et al. BMJ Open 2017;7:e013889. doi:10.1136/bmjopen-2016-013889
Open Access
group.bmj.com on April 28, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
utilitarian walking.21 Owing to the link between margin-
alisation and health, the Ontario Marginalization Index
scores of Toronto neighbourhoods were also included as
covariates.46 47 This index uses census data and assigns
scores across four speciﬁc dimensions that contribute to
the process of marginalisation. Material deprivation
scores incorporated measures of unemployment, low
income, low education and low-quality housing. Ethnic
concentration scores accounted for recent immigration
and self-identiﬁcation as a visible minority. Residential
instability scores were derived from multiple indicators,
including the proportion of the population who had
moved in the previous 5 years, and the proportion of
dwellings that were not owned. Dependency scores
included indicators measuring the proportion of the
population aged 65 and older and the proportion of the
population not participating in the labour force.46 47
Statistical analyses
Descriptive statistics were calculated for demographic
variables, health outcome measures and all covariates.
Toronto neighbourhood walkability was visualised with a
choropleth map. Means and 95% CIs of all health mea-
sures were calculated for the highest and lowest neigh-
bourhood walkability quartiles and signiﬁcance testing
was performed on the unadjusted means using t-tests
assuming equal variances. Multivariable linear regression
models were also used to compare the mean health
measures in the highest versus the lowest walkability
quartile. All models were adjusted for covariates of age,
sex, smoking status, neighbourhood rates of violent
crime and neighbourhood indices of material depriv-
ation, ethnic concentration, residential instability and
dependency from the Ontario Marginalization Index.
Models predicting BMI were also adjusted for the pres-
ence of a weight-loss medication. Models predicting
blood pressure were adjusted for BMI, the presence of a
hypertension diagnosis and prescription of antihyperten-
sive medication. Models predicting HbA1c and FBG
were adjusted for BMI, the presence of a diabetes diag-
nosis and prescription of antidiabetic medication.
Models predicting cholesterol (TC, HDL, LDL, TG)
were adjusted for BMI and the presence of a prescrip-
tion for lipid-lowering medication. There were insufﬁ-
cient observations within each neighbourhood to use
multilevel models. However, to ensure that the use of
non-hierarchical linear regression was appropriate, intra-
class correlation coefﬁcients (ICCs) were calculated.
Low ICCs for each health outcome (ICC=0.050 for BMI,
ICC<0.01 for all other outcomes) revealed that very little
of the total variance was accounted for by clustering
within neighbourhoods, and that a non-hierarchical
approach was reasonable.
Differences in health measures across walkability quar-
tiles were examined for all ages, and in stratiﬁed analyses
across three age subgroups of 18 to under 40 years, 40–
65 years and over 65 years. Broadly, these age categories
represent segments of the population where primary
versus secondary prevention strategies may be relevant
in distinct ways. A younger adult population is more
amenable to primary prevention of chronic disease. The
primary and secondary prevention are relevant for
middle-aged adults, and notably, they undergo lipid and
diabetes screening as recommended by clinical practice
guidelines.15 48 Finally, older adults may differ from
younger adults due to increased medical comorbidities
that affect the health markers of interest, and due to
potentially decreased mobility that may affect levels of
walking and physical activity.
All data were analysed using Stata IC/V.12.1 and
mapping was carried out using ESRI ArcGIS ArcMap
V.10.1.
RESULTS
A total of 78 023 UTOPIAN patients met the inclusion
criteria. The generation of the study sample is displayed
in ﬁgure 1.
Characteristics of the study sample are displayed in
table 1. Residents of the lowest and highest quartiles of
neighbourhood walkability were similar with respect to
age, proportion of women and proportion of smokers.
Neighbourhoods in the highest walkability quartile had
higher violent crime rates, somewhat lower deprivation
scores, but similar ethnic concentration compared with
neighbourhoods in the lowest quartile. A map of
Toronto’s 140 neighbourhoods and their Walk Scores is
displayed in ﬁgure 2. The most walkable neighbour-
hoods were concentrated in Toronto’s downtown core.
Neighbourhood Walk Scores ranged from 42 to 99.
Unadjusted means and 95% CIs for all health mea-
sures in the lowest and highest quartiles of neighbour-
hood walkability are displayed in table 2. All differences
in unadjusted means were signiﬁcant at the p<0.001
level.
Table 3 displays the adjusted linear regression coefﬁ-
cients comparing differences in the mean health mea-
sures between the highest and lowest quartiles of
neighbourhood walkability. Data for all quartiles are
reported in online supplementary table S1. After adjust-
ing for covariates, there were statistically signiﬁcant dif-
ferences in average measures of BMI, sBP, dBP, HbA1c
and HDL between participants in the highest versus the
lowest walkability quartile.
Figure 1 Sequence of steps in generation of study sample.
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Table 1 Descriptive characteristics of study participants
Lowest quartile of neighbourhood walkability
Highest quartile of neighbourhood
walkability Total study population
Characteristic
Frequency
(%) Mean (SD)
N patients with
data
Frequency
(%) Mean (SD)
N patients with
data
Frequency
(%) Mean (SD)
N patients with
data
Sex (female) 11 303 (62.3%) 18 137 11 399 (62.7%) 18 192 48 556
(62.2%)
78 022
Age (years) 49.2 (19.2) 18 122 48.5 (17.9) 18 180 50.0 (19.2) 77 966
18≤age<40 6448 (35.6%) 6895 (37.9%) 26 977
(34.6%)
40<age≤65 7731 (42.7%) 7760 (42.7%) 33 056
(42.4%)
>65 years 3943 (21.8%) 3525 (19.4%) 17 933
(23.0%)
Smoking (current smoker) 1530 (12.0%) 12 772 1669 (13.3%) 12 511 6808 (12.1%) 56 093
Anthropometric indicators
Body mass index (BMI) (kg/m2) 29.6 (10.0) 9819 26.0 (6.22) 10 920 27.2 (7.4) 46 029
Overweight or obese (BMI≥25 kg/m2) 6370 (64.9%) 9819 5505 (50.4%) 10 920 26 309
(57.2%)
46 029
Prescribed weight-loss medication 1146 (6.3%) 18 137 523 (2.9%) 18 192 3387 (4.3%) 78 023
Blood pressure control
Hypertension diagnosis 4068 (22.4%) 18 137 2980 (16.4%) 18 192 16 241
(20.8%)
78 023
Prescribed antihypertensive medication 4796 (26.4%) 18 137 3555 (19.5%) 18 192 19 020
(24.4%)
78 023
Systolic blood pressure (sBP) (mm Hg) 121.5 (16.0) 13 722 117.4 (15.5) 13 950 119.8 (16.0) 59 634
Diastolic blood pressure (dBP) (mm Hg) 75.0 (10.0) 13 722 73.1 (10.0) 13 950 73.8 (10.0) 59 634
Blood glucose control
Diabetes diagnosis 2242 (12.4%) 18 137 1096 (6.0%) 18 192 6988 (9.0%) 78 023
Prescribed antidiabetic medication 1788 (9.9%) 18 137 786 (4.3%) 18 192 5220 (6.7%) 78 023
Haemoglobin A1c (HbA1c) (%) 6.10 (1.10) 6721 5.74 (0.75) 5570 5.89 (0.88) 29 575
Fasting blood glucose (FBG) (mmol/L) 5.56 (1.70) 8388 5.32 (1.26) 6367 5.42 (1.46) 34 698
Lipid control
Prescribed lipid-lowering medication 3686 (20.3%) 18 137 2453 (13.5%) 18 192 13 979
(17.9%)
78 023
Total cholesterol (TC) (mmol/L) 4.73 (1.08) 8690 4.93 (1.04) 6825 4.81 (1.06) 36 498
High-density lipoprotein (HDL) (mmol/L) 1.43 (0.41) 8844 1.58 (0.47) 7014 1.49 (0.44) 37 295
Low-density lipoprotein (LDL) (mmol/L) 2.71 (0.90) 8770 2.78 (0.88) 6983 2.74 (0.89) 37 097
Triglycerides (TG) (mmol/L) 1.34 (1.05) 8883 1.26 (0.79) 7008 1.31 (0.87) 37 417
Neighbourhood violent crime rate*
(events/10 000 residents)
95.4 (49.8) 18 137 128.2 (84.3) 18 192 91.3 (59.6) 78 023
Neighbourhood instability score† −0.048 (0.48) 18 137 1.37 (0.68) 18 192 0.480 (0.71) 78 023
Neighbourhood deprivation score† 0.30 (0.96) 18 137 −0.53 (0.69) 18 192 −0.170 (0.77) 78 023
Neighbourhood ethnic concentration score† 1.78 (0.89) 18 137 0.82 (0.89) 18 192 1.353 (1.08) 78 023
Neighbourhood dependency score† −0.020 (0.36) 18 137 −0.44 (0.27) 18 192 −0.100 (0.39) 78 023
N, number of observations in study sample.
*Violent crime includes occurrences of assault, sexual assault, robbery and murder.
†Scores of neighbourhood instability, deprivation, ethnic concentration and dependency are dimensions of the Ontario Marginalization Index.49 Scores are population-weighted, and higher
values indicate greater instability/deprivation/ethnic concentration/dependency.
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The mean BMI was 2.64 kg/m2 lower (95% CI −2.98
to −2.30, p<0.001) among individuals in the highest
versus the lowest neighbourhood walkability quartile. In
the stratiﬁed analyses, this difference was greatest in
those aged 18 to under 40, where the mean BMI was
−4.44 kg/m2 lower (95% CI −5.09 to 3.79, p<0.001),
and smallest in those over age 65, where the mean BMI
was 0.87 kg/m2 lower (95% CI −1.48 to −0.26, p=0.005).
When comparing average blood pressure measurements
of individuals in the highest versus the lowest walkability
quartile, the mean sBP was 1.35 mmHg lower (95% CI
−2.01 to −0.70, p<0.001) and the mean dBP was
0.60 mmHg lower (95% CI −1.06 to −0.14, p=0.010). When
stratifying by age categories, signiﬁcant differences in the
mean sBP and dBP were observed only in those aged 40–65.
With respect to blood glucose control, the mean
HbA1c was 0.063% lower (95% CI −0.11 to−0.021,
p=0.003) in those within the highest neighbourhood
walkability quartile compared with those in the lowest
quartile. After age stratiﬁcation, a statistically signiﬁcant
difference was only present in those aged 18 to under
40. No evidence of differences in the mean FBG was
observed between the highest and the lowest quartiles of
neighbourhood walkability.
In terms of cholesterol parameters, the mean HDL was
0.052 mmol/L higher (95% CI 0.029 to 0.075, p<0.001)
in those in the highest versus the lowest neighbourhood
walkability quartile. Across the age subgroups, a signiﬁ-
cant difference in the mean HDL was present only in the
two older age categories. The difference observed in the
mean TC was of borderline statistical signiﬁcance, and in
the stratiﬁed analyses, was only signiﬁcant in those aged
40–65. No strong evidence of differences in other choles-
terol parameters was apparent.
Figure 2 Map of Toronto
neighbourhood walkability as
measured by neighbourhood
Walk Scores. Walk Scores for
Toronto neighbourhoods (n=140)
were retrieved from the City of
Toronto Open Data Catalogue.40
Table 2 Unadjusted means and 95% CIs for health measures in the lowest and highest quartiles of neighbourhood walkability
Health measure (unit)
Mean (95% CI) in lowest quartile of
neighbourhood walkability
Mean (95% CI) in highest quartile
of neighbourhood walkability
Body mass index (BMI) (kg/m2) 29.6 (29.5 to 29.8) 26.0 (25.9 to 26.2)*
Systolic blood pressure (sBP) (mm Hg) 121.5 (121.2 to 121.7) 117.4 (117.2 to 117.7)*
Diastolic blood pressure (dBP) (mm Hg) 75.0 (74.8 to 75.1) 73.1 (72.9 to 73.3)*
Haemoglobin A1c (HbA1c) (%) 6.10 (6.08 to 6.12) 5.74 (5.72 to 5.76)*
Fasting blood glucose (FBG) (mmol/L) 5.56 (5.53 to 5.59) 5.32 (5.28 to 5.35)*
Total cholesterol (TC) (mmol/L) 4.73 (4.71 to 4.75) 4.93 (4.91 to 4.96)*
High-density lipoprotein (HDL) (mmol/L) 1.43 (1.42 to 1.44) 1.58 (1.57 to 1.59)*
Low-density lipoprotein (LDL) (mmol/L) 2.71 (2.69 to 2.73) 2.78 (2.76 to 2.80)*
Triglycerides (TG) (mmol/L) 1.34 (1.32 to 1.36) 1.26 (1.24 to 1.28)*
*Significant difference between the unadjusted means at the highest versus the lowest walkability quartile, using t-tests at a significance level
of p<0.001.
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DISCUSSION
Key findings: neighbourhood walkability and metabolic
risk factors
We observed an association between higher neighbour-
hood walkability and objectively measured metabolic risk
factors. The magnitude of differences observed for BMI
across all age groups and for blood pressure in
middle-aged adults was clinically signiﬁcant and relevant
for population health.
Strengths and limitations
The main strength of this study is that it used EMR data
to examine a set of clinical measures known to change
with physical activity, all of which were objectively mea-
sured through physical examination or laboratory
testing. The study controlled for individual clinical
attributes as well as neighbourhood-level covariates that
could have confounded the relationship between neigh-
bourhood walkability and the metabolic risk factors of
interest.28 32 50 51
Overall, the study population included a large and
diverse sample of adults of all ages, with and without
chronic disease. However, the application of the study
ﬁndings to other adult populations in a developed,
urban setting should also consider that these were
primary care patients. In particular, the study population
did not include children or adolescents, had more older
adults and had a greater proportion of women than the
general population of Toronto.52 With respect to major
comorbidities, the prevalence of hypertension and dia-
betes in the study sample (20.8% and 9.0%, respect-
ively) were comparable to the prevalence of these
Table 3 Adjusted linear regression coefficients comparing differences in the mean health measures between the highest
and lowest quartiles of neighbourhood walkability
Health measure (unit) Regression coefficient (95% CI) p Value
BMI (kg/m2)—all ages≥ 18 −2.64 (−2.98 to −2.30) <0.001
18 ≤ age <40 −4.44 (−5.09 to −3.79) <0.001
40 ≤ age ≤65 −2.74 (−3.24 to −2.23) <0.001
Age > 65 −0.87 (−1.48 to −0.26) 0.005
sBP (mm Hg)—all ages≥18 −1.35 (−2.01 to −0.70) <0.001
18 ≤ age <40 −0.64 (−1.68 to 0.41) 0.23
40 ≤ age ≤65 −1.97 (−2.91 to −1.03) <0.001
Age > 65 −0.64 (−2.14 to 0.85) 0.40
dBP (mm Hg)—all ages≥18 −0.60 (−1.06 to −0.14) 0.010
18 ≤ age <40 0.12 (−0.68 to 0.93) 0.76
40 ≤ age ≤65 −1.30 (−1.94 to −0.66) <0.001
Age > 65 −0.19 (−1.13 to 0.75) 0.69
HbA1c (%)—all ages≥ 18 −0.063 (−0.11 to −0.021) 0.003
1 8 ≤ age <40 −0.12 (−0.23 to −0.019) 0.021
40 ≤ age ≤65 −0.059 (−0.12 to 0.0026) 0.060
Age > 65 −0.013 (−0.078 to 0.051) 0.69
FBG (mmol/L)—all ages≥ 18 0.030 (−0.038 to 0.099) 0.39
18 ≤ age <40 −0.086 (−0.24 to 0.073) 0.29
40 ≤ age ≤65 0.028 (−0.068 to 0.12) 0.57
Age > 65 0.083 (−0.036 to 0.20) 0.17
TC (mmol/L)—all ages≥ 18 0.061 (0.00025 to 0.12) 0.049
18 ≤ age <40 −0.023 (−0.18 to 0.13) 0.77
40 ≤ age ≤65 0.11 (0.024 to 0.19) 0.012
Age > 65 −0.023 (−0.13 to 0.078) 0.65
HDL (mmol/L)—all ages≥18 0.052 (0.029 to 0.075) <0.001
18 ≤ age <40 0.022 (0.038 to 0.081) 0.47
40 ≤ age ≤65 0.052 (0.020 to 0.084) 0.001
Age > 65 0.060 (0.019 to 0.10) 0.004
LDL (mmol/L)—all ages≥ 18 0.010 (−0.041 to 0.062) 0.69
18 ≤ age <40 −0.0088 (−0.14 to 0.12) 0.89
40 ≤ age ≤65 0.026 (−0.044 to 0.096) 0.47
Age > 65 −0.036 (−0.12 to 0.049) 0.41
Triglyceride (mmol/L)—all ages≥ 18 −0.0031 (−0.053 to 0.047) 0.90
18≤ age <40 −0.14 (−0.33 to 0.047) 0.14
40≤ age≤65 0.038 (−0.029 to 0.11) 0.27
Age >65 −0.041 (−0.11 to 0.033) 0.28
Results are presented for all ages and for each age subcategory. Regression coefficients represent differences in the mean health measure,
adjusting for covariates of age, sex, current smoking status, BMI (except in the model where BMI is the health outcome measure) relevant
medications and medical diagnoses, neighbourhood violent crime rates and neighbourhood indices of material deprivation, ethnic
concentration, dependency and residential instability.
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diseases in the general population of Toronto (22.7%
and 10.4%, respectively).53 54 The study sample had a
higher prevalence of overweight or obesity of 57.2%
compared with the published Toronto prevalence of
45.8%.53 This may be related to the fact that the latter
value is from self-reported population survey data, which
is prone to under-reporting of BMI.55 National estimates
that use directly measured BMI yield an overweight or
obesity prevalence of 62%.56 Given that CPCSSN is the
ﬁrst multidisease, EMR-based surveillance system in
Canada, further work would be of interest to character-
ise the sociodemographic and health attributes of par-
ticipating patient populations, especially in relation to
the general population.
The main limitation of this study is its cross-sectional
nature, which precludes the establishment of temporality
in the association between neighbourhood walkability
and health outcomes. Importantly, it is not possible to
rule out a residential selection effect, in which healthier
individuals who choose to engage in more health-
promoting behaviours, such as physical activity, may also
choose to live in more walkable areas to facilitate their
preferred lifestyle. In other studies that either controlled
for neighbourhood self-selection or were longitudinal in
design, signiﬁcant associations were still observed
between neighbourhood walkability and levels of over-
weight or obesity.57 58 This study did not control for
leisure physical activity, which may also inﬂuence the
measured clinical outcomes, but—unlike utilitarian
walking—is not thought to be a key mediator of the
putative health beneﬁts of walkable built environ-
ments.20 21 29 59 Based on a recent study in Ontario,
Canada, which found that differences in leisure physical
activity were not signiﬁcant between individuals from
areas of varying walkability,29 any signiﬁcant confound-
ing by leisure physical activity would have biased results
towards the null and led to underestimation of effects in
the present study. Dietary information could not be cap-
tured in a valid manner using EMR data in this study. It
is possible that dietary habits, particularly as linked to
the food environment, may differ between neighbour-
hoods of high versus low walkability,60 61 but the extent
to which this may have affected estimates in this study is
unclear. Similarly, this study did not control for major
disabilities or mobility limitations which may have pre-
cluded engagement in utilitarian walking in affected par-
ticipants. This may have contributed to the attenuation
of differences in the mean BMI observed in older
adults. Future work that controls for mobility limitations
would be of interest to better explore the effects of
neighbourhood walkability in older populations, particu-
larly given that an association between walkability and
physical activity has been previously reported in adults
aged 65 and older.62
Findings in relation to other studies
The BMI ﬁndings are consistent with several recent
studies which demonstrated lower prevalence of obesity
in high-walkability neighbourhoods compared with low-
walkability neighbourhoods.29 30 33 34 Importantly, this
study quantiﬁed the magnitude of the mean difference
in BMI that was observed (2.64 kg/m2), and found that
this clinically meaningful difference varied across three
age categories. In a previous longitudinal study of 701
participants, residential relocation involving a 10-point
increase in street address Walk Score was associated with
an average within-individual BMI reduction of 0.06 kg/
m2.57 The magnitude of this effect was smaller than the
2.64 kg/m2 difference in the mean BMI that was
observed in this study, between the highest and lowest
neighbourhood walkability quartiles (a difference of
about 20–60 points in aggregate neighbourhood Walk
Score). Importantly, the scale at which walkability was
measured in the present study was at the larger neigh-
bourhood level, rather than at the level of each resi-
dent’s individual address. This has interesting
implications for determining the spatial scale at which a
built environment might exert positive health effects
mediated by walkability and utilitarian physical activity.
With respect to blood pressure, one previous study
that measured walkability and fast-food outlet density
reported an association with blood pressure decreases in
older adults,60 while another study found no association
between walkability and self-reported hypertension.34
The effect size of aerobic exercise on blood pressure
reduction has been reported as −3.84 mm Hg for sBP
and −2.58 mm Hg for dBP.63 Thus, it is plausible that
the small differences in the mean sBP and dBP in the
current study may be attributable to differences in levels
of utilitarian walking. In the age-stratiﬁed analyses, only
adults aged 40–65 demonstrated a signiﬁcant difference
in the mean sBP and dBP. In Canada, the age-speciﬁc
prevalence of hypertension follows an S-shaped curve,
with a prevalence of 5.7% in adults aged 35–39, which
rises steadily from 9.3% in adults aged 40–44 to 53.6%
in adults aged 65–69.64 The lack of association in
younger adults may be related to insufﬁcient power in
this study to detect blood pressure differences where
hypertension prevalence is low. Alternatively, an associ-
ation between walkable neighbourhoods and blood pres-
sure may not exist or be relevant in younger adults, for
which the incidence and risk of hypertension is already
quite low (<1% incidence in Canadians under 40 years
of age).64 In older adults, potential explanations for a
lack of an association include decreased mobility and
ability to engage in utilitarian walking, or the possibility
that physical activity effects on blood pressure become
relatively insigniﬁcant in the context of multiple medica-
tions and comorbidities in this age group.
Although previous studies have found an association
between neighbourhood walkability and both the preva-
lence and incidence of diabetes,30 32 33 associations
between neighbourhood walkability and HbA1c have not
been reported. In a systematic review and meta-analysis
of 23 RCTs, structured aerobic exercise durations of
150 min or less per week were found to be associated
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with HbA1c reductions of 0.36%.65 The observed differ-
ence in the mean HbA1c in this study was considerably
smaller. This suggests that the level of physical activity
potentially promoted by a more walkable neighbour-
hood may not be strongly associated with clinically sig-
niﬁcant changes to HbA1c. Another possibility is that
the observed relationship between neighbourhood walk-
ability and the mean HbA1c may have been confounded
by variations in individual diet as well as in the larger
food environment. Furthermore, given that neighbour-
hood walkability is associated with BMI and obesity
prevalence, both of which inﬂuence the risk of diabetes,
this may explain the ﬁnding of higher incidence and
prevalence of diabetes in higher walkability neighbour-
hoods, rather than simply an independent effect of walk-
ability on diabetes.
An association between neighbourhood walkability
and objective cholesterol parameters has not been previ-
ously reported in the peer-reviewed literature. One pre-
vious study reported a lack of an association between
walkability and self-reported hypercholesterolaemia.34 In
a Cochrane review of exercise effects on overweight or
obesity, an HDL improvement of 0.06 mmol/L was
found among those who engaged in moderate aerobic
exercise compared with controls with no treatment.66
This suggests that, in the current study, the observed dif-
ference in the mean HDL between the highest and
lowest neighbourhood walkability quartiles is of a magni-
tude that could be plausibly attributed to a physical activ-
ity effect. The lack of consistent differences in other
cholesterol parameters between the highest and lowest
walkability quartiles is not incompatible with the litera-
ture. Indeed, a review of 51 studies, including 28 RCTs,
of the effect of aerobic exercise training on blood lipids
found that an increase in HDL was the most frequently
observed outcome, and reductions in TC, LDL and TG
were less commonly seen.67 Again, the current study did
not control for dietary factors, which are known to inﬂu-
ence cholesterol parameters,68 and the observed associa-
tions should be interpreted with this in mind.
Implications of findings for population health
From a clinical perspective, recognising the relative walk-
ability of a patient’s residential neighbourhood may aid
health providers in making context-appropriate physical
activity recommendations for health maintenance and
chronic disease management. More importantly, the
implications for walkable environments as a public
health intervention are signiﬁcant if the health associa-
tions for walkability presented in this and other studies
represent a truly causal relationship. In other words, a
highly walkable neighbourhood could represent a
population-wide intervention capable of conferring mul-
tiple beneﬁts related to obesity prevention, blood pres-
sure control and potentially even blood glucose and
lipid control. At the population level, even small
changes in average BMI or blood pressure have the
potential to ‘shift the curve’ with respect to the
population distribution of disease risk. By lowering the
average level of risk factors, such a population strategy
targets the determinants of disease incidence and may
have the capacity to prevent a considerable fraction of
obesity, hypertension, diabetes and cardiovascular
disease that is attributed to physical inactivity.69 70
One ﬁnal issue of relevance for policymakers is that of
equity. This study demonstrated that across 140 neigh-
bourhoods within a single city, variations in health
existed based on walkability characteristics of the built
environment. Addressing the determinants of health
and health equity at the population level should there-
fore include built environment considerations, such as
access to public transportation and safe pedestrian
infrastructure.
CONCLUSIONS
There is a clinically meaningful association between
living in a neighbourhood in the highest walkability
quartile and having lower BMI and modestly lower blood
pressure. This study demonstrates that EMR data can be
a source of objective clinical measures for population
health research. Further longitudinal studies on walkable
environments are needed to provide a realistic estimate
of the magnitude and distribution of their health effects
on the population, and to clarify the spatial scale at
which neighbourhood walkability realises these effects.
Further research is also needed to examine the broader
health and non-health impacts of walkable neighbour-
hoods, particularly if they are implemented as a built
environment intervention at the population level.
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